Medical Marijuana, Inc. Announces Investment in AXIM Biotechnologies

 

Cutting-Edge Global Industrial Hemp-Based Biotechnology Company Brings Added Diversity in Food and Pharmaceuticals to MJNA’s Growing Investment Portfolio

 

 

Big news out of San Diego, California as Medical Marijuana, Inc. (OTC: MJNA) has acquired 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies, a cutting-edge biotechnology innovator. Stuart W. Titus, PhD, President and CEO of Medical Marijuana Inc. mentions: “We are extremely excited to announce our strategic ownership interest in AXIM Biotech and explain to MJNA’s shareholders some of the important innovations that Dr. Anastassov and the AXIM team are focused on. AXIM Biotech’s recent announcements include hemp-based innovations that provide consumers a wide variety of new options worldwide.”

What is AXIM Biotechnologies?

AXIM Biotech is a unique biotechnology company focused on global research, development and production of pharmaceutical, food,...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
https://www.cashinbis.com/medical-marijuana-inc-announces-investment-in-axim-biotechnologies